German Guerrero

Executive Medical Director & Launch Lead, Atacicept – IgA Nephropathy at Vera Therapeutics

Speaker

German Guerrero, M.D. is Executive Medical Director and Launch Lead at Vera Therapeutics, where he leads Medical Affairs strategy and U.S. launch preparation for atacicept, a first-in-class therapy in IgA nephropathy. With over two decades in Medical Affairs, German has led cross-functional launch teams across cardiorenal, metabolic, and rare disease at Bayer, Novo Nordisk, and other leading pharma and biotech organizations. His approach centers on building enterprise-scale alignment frameworks that connect Clinical, Commercial, Market Access, and Regulatory teams around shared decision architecture. German holds an M.D. from La Salle University in Mexico City.